This summit includes two parallel conferences bringing together experts from industry, academia and government to discuss emerging targets, therapeutics, progress in cancer immunotherapy, and strategies against cancer. In addition, focuses on business development trends, partnership opportunities, value maximization/capital efficiency, and the return of biotech IPOs will also be discussed.
The Novel Cancer Therapeutics Summit 2014, includes two parallel conferences:
2nd Oncology Partnering & Deal-Making
4th Cancer Targets & Therapeutics